Tel Aviv, Israel, December 8th, 2025, FinanceWireRecognition by the European Crohn’s and Colitis Organisation marks a ...
GLP-1 RAs are safe and efficacious for adults with IBD, with no increased risk for flare-ups, hospitalization, corticosteroid use, or operation.
Long-term isotretinoin use is not associated with increased inflammatory bowel disease in a retrospective cohort study using ...
Clinical Evolution of Diagnostic Testing with New Scientific Insights SAN DIEGO, CA / ACCESS Newswire / December 8, 2025 / ...
Investor's Business Daily on MSN
Structure Therapeutics soars; CEO says it could have 'best-in-class' weight-loss drug
Structure TherapeuticsGPCR shares skyrocketed Monday after the company said patients who took a high dose of its ...
Spyre Therapeutics (SYRE) has strong technical momentum and is trading at a new 52 week high. SYRE maintains a 100% “Buy” ...
Investor's Business Daily on MSN
Kymera rockets, pulling Nurix higher. Does it have the next Dupixent?
Kymera TherapeuticsKYMR could have the next Dupixent, analysts said Monday, as shares skyrocketed on promising test results ...
A woman on clozapine develops severe gastrointestinal hypomotility that progresses to toxic megacolon and multiorgan failure, ...
Alcohol can lead to reduced absorption of xylose (a type of sugar). This means diarrhoea is more likely to occur in drinkers ...
Detailed price information for Ventyx Biosciences Inc (VTYX-Q) from The Globe and Mail including charting and trades.
Detailed price information for Ventyx Biosciences Inc (VTYX-Q) from The Globe and Mail including charting and trades.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback